Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Current Deferred Revenue (2016 - 2022)

Inogen has reported Current Deferred Revenue over the past 10 years, most recently at $9.1 million for Q3 2022.

  • Quarterly results put Current Deferred Revenue at $9.1 million for Q3 2022, up 8.25% from a year ago — trailing twelve months through Sep 2022 was $9.1 million (up 8.25% YoY), and the annual figure for FY2021 was $8.6 million, up 22.51%.
  • Current Deferred Revenue for Q3 2022 was $9.1 million at Inogen, up from $9.0 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for INGN hit a ceiling of $17.1 million in Q4 2019 and a floor of $3.2 million in Q1 2018.
  • Median Current Deferred Revenue over the past 5 years was $6.8 million (2020), compared with a mean of $7.1 million.
  • Biggest five-year swings in Current Deferred Revenue: surged 283.69% in 2019 and later tumbled 59.05% in 2020.
  • Inogen's Current Deferred Revenue stood at $4.5 million in 2018, then surged by 283.69% to $17.1 million in 2019, then crashed by 59.05% to $7.0 million in 2020, then grew by 22.51% to $8.6 million in 2021, then increased by 6.43% to $9.1 million in 2022.
  • The last three reported values for Current Deferred Revenue were $9.1 million (Q3 2022), $9.0 million (Q2 2022), and $8.7 million (Q1 2022) per Business Quant data.